Guangzhou Baiyunshan Pharmaceutical Holdings Company (GU5) Stock Statistics & Valuation Metrics

Guangzhou Baiyunshan Pharmaceutical Holdings Company has a market cap or net worth of EUR 4.10B. The enterprise value is EUR 37.68B.

Market Cap

EUR 4.10B

Enterprise Value

EUR 37.68B

Guangzhou Baiyunshan Pharmaceutical Holdings Company has 219,900,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

219,900,000

Owned by Insiders

―

Owned by Institutions

9.52%

Guangzhou Baiyunshan Pharmaceutical Holdings Company’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.81%.

Return on Equity (ROE)

0.08

Return on Assets (ROA)

0.04

Return on Invested Capital (ROIC)

4.81%

Return on Capital Employed (ROCE)

0.08

Revenue Per Employee

2.87M

Profits Per Employee

110.25K

Employee Count

27,057

Asset Turnover

0.92

Inventory Turnover

4.95

The current PE Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company is 14.97. Guangzhou Baiyunshan Pharmaceutical Holdings Company’s PEG ratio is -0.54.

PE Ratio

14.97

PS Ratio

0.39

PB Ratio

0.83

Price to FCF

20.92

Price to Operating Cash Flow

12.72

PEG Ratio

-0.54

In the last 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 77.66B and earned 2.98B in profits. Earnings per share was 1.83.

Revenue

77.66B

Gross Profit

12.52B

Operating Income

3.63B

Pretax Income

3.69B

Net Income

2.98B

EBITDA

3.95B

Earnings Per Share (EPS)

1.83

In the last 12 months, operating cash flow was 2.48B and capital expenditures -1.09B, giving a free cash flow of 1.39B billion.

Operating Cash Flow

2.48B

Free Cash Flow

1.39B

Free Cash Flow per Share

0.90

Guangzhou Baiyunshan Pharmaceutical Holdings Company pays an annual dividend of ―, resulting in a dividend yield of 4.67%

Dividend Per Share

―

Dividend Yield

4.67%

Payout Ratio

N/A

Free Cash Flow Yield

4.78%

Earnings Yield

6.69%

Beta

0.09

52-Week Price Change

-30.48%

50-Day Moving Average

1.45

200-Day Moving Average

1.64

Relative Strength Index (RSI)

52.76

Average Volume (3m)

300

Guangzhou Baiyunshan Pharmaceutical Holdings Company upcoming earnings date is Mar 12, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 28, 2026

Next Earnings Date

Mar 12, 2027

Ex-Dividend Date

―

Guangzhou Baiyunshan Pharmaceutical Holdings Company as a current ratio of 1.57, with Debt / Equity ratio of 54.75%

Current Ratio

1.57

Quick Ratio

1.24

Debt to Market Cap

0.79

Net Debt to EBITDA

1.46

Interest Coverage Ratio

8.72

In the past 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Company has paid 629.22M in taxes.

Income Tax

629.22M

Effective Tax Rate

0.17

Guangzhou Baiyunshan Pharmaceutical Holdings Company EV to EBITDA ratio is 12.18, with an EV/FCF ratio of 28.69.

EV to Sales

0.54

EV to EBITDA

12.18

EV to Free Cash Flow

28.69

EV to Operating Cash Flow

16.46

Guangzhou Baiyunshan Pharmaceutical Holdings Company has EUR 11.90B in cash and marketable securities with EUR 23.24B in debt, giving a net cash position of -EUR 11.34B billion.

Cash & Marketable Securities

EUR 11.90B

Total Debt

EUR 23.24B

Net Cash

-EUR 11.34B

Net Cash Per Share

-EUR 51.57

Tangible Book Value Per Share

EUR 22.93

Gross margin is 15.02%, with operating margin of 3.00%, and net profit margin of 2.77%.

Gross Margin

15.02%

Operating Margin

3.00%

Pretax Margin

3.44%

Net Profit Margin

2.77%

EBITDA Margin

4.40%

EBIT Margin

3.78%

The average price target for Guangzhou Baiyunshan Pharmaceutical Holdings Company is EUR 2.35, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

EUR 2.35

Price Target Upside

60.65% Upside

Analyst Consensus

Moderate Buy

Analyst Count

1

Revenue Growth Forecast

0.35%

EPS Growth Forecast

-27.77%

Smart Score

7

AI Score

―